BioSpace News Archive

Tempus, a leader in artificial intelligence and precision medicine, today announced a multi-year, strategic collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) in which the two companies will work together to gather insights, discover novel drug targets, and aim to develop therapeutics for the broader oncology community.

BioMarin Pharmaceutical Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to VOXZOGO™ (vosoritide) for Injection, indicated to increase linear growth in pediatric patients with achondroplasia five years of age and older with open epiphyses (growth plates).

The Circul8 Pro® DVT prevention device is now available with a 20-plus-hour battery life.

ArsenalBio today announced that Company leadership will participate in two upcoming virtual investor conferences: Piper Sandler 33rd Annual Virtual Healthcare Conference Format: On-Demand Presentation Date: November 29 – December 2, 2021.

Adamis Pharmaceuticals Corporation today announced that it will host an investor conference call on Monday, November 22, 2021 at 2 p.m. Pacific Time to discuss its financial and operating results for the first nine months of 2021, as well as provide a business update.

Vor Biopharma will be participating at the Piper Sandler 33rd Virtual Annual Healthcare Conference. Piper Sandler 33rd Virtual Annual Healthcare Conference Date: Tuesday, November 30 through Thursday, December 2, 2021.

Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, announced that company management will participate at two upcoming investor conferences.

Quidel Presents at 33rd Annual Piper Sandler Healthcare Conference.